IPO
-
-
-
-
-
-
-
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
-
-
-
-
-
-
-
Greenwich LifeSciences (GLSI) Announces Publication of Positive Phase IIb Clinical Trial Data for GP2, Its Lead Drug Candidate for the Prevention of Recurring Breast Cancer
-
-
-
-
-
118,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

